CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Fresenius Kabi USA, LLC v. Sagent Pharmaceuticals, Inc.

1:17-cv-00011

Overview

Case Number 1:17-cv-00011
Filing Date 2017-01-04
Status Terminated
Termination Date 2017-06-09
Court District Court, D. Delaware (ded)
Presiding Judge Leonard P. Stark
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Sagent Pharmaceuticals, Inc.

Represented By

1 Attorneys Listed

Kenneth Laurence Dorsney

Morris James LLP

Tel: +1 (302) 888-6855
Fax: +1 (302) 571-1750

500 Delaware Avenue, Suite 1500, P.O. Box 2306

Plaintiff

Fresenius Kabi Deutschland GmbH

Represented By

2 Attorneys Listed

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Fresenius Kabi USA, LLC

Represented By

2 Attorneys Listed

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Presiding Judge

Leonard P. Stark

Patents Involved

2 Patents

There are 2 patents involved in this case.

Docket Entries

COMPLAINT FOR PATENT INFRINGEMENT filed against Sagent Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2058707.) - filed by Fresenius Kabi USA, LLC, Fresenius Kabi Deutschland GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(jcs) (Entered: 01/05/2017)

2017-01-04
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 01/05/2017)

2017-01-04
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 22, 2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/22/2019. (jcs) (Entered: 01/05/2017)

2017-01-04
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,118,802 B2; US 8,162,915 B2. (jcs) (Entered: 01/05/2017)

2017-01-04
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc